in
  1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2009). (Text Available).
  2. Miller MR, Crapo R, Hankinson J, et al. American Thoracic Society/European Respiratory Society Task Force: Standardisation of lung function testing. General considerations for lung function testing. Eur Respir J. 2005;26:153. (Ref)
  3. Barreiro TJ, Perillo I. An approach to interpreting spirometry. Am Fam Physician. 2004;69:1107. (Abstract)
  4. Petty TL. Benefits of and barriers to the widespread use of spirometry. Curr Opin Pulm Med. 2005;11:115. (Abstract)
  5. Mahler D, Wells C. Evaluation of clinical methods for rating dyspnea. Chest.1988;93:580-586. (Abstract)
  6. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581-586. (Abstract)
Copyright © 2010, 2011  Perelman School of Medicine at the University of Pennsylvania Office of Continuing Medical Education & BestPractice CPD, LLC®. All rights reserved.